I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Final Overall Survival, Safety, and Quality of Life Results..:
Yi-Long Wu, MD
;
Shun Lu, MD, PhD
;
James Chih-Hsin Yang, MD, PhD
...
http://www.sciencedirect.com/science/article/pii/S2666364322001308. , 2022
Link:
https://doi.org/10.1016/j.jtocrr.2022.100406
RT Journal T1
Final Overall Survival, Safety, and Quality of Life Results From a Phase 2 Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced NSCLC
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:7369e36175e44454b80a3ac673b3634f&Exemplar=1&LAN=DE A1 Yi-Long Wu, MD A1 Shun Lu, MD, PhD A1 James Chih-Hsin Yang, MD, PhD A1 Jianying Zhou, MD A1 Takashi Seto, MD A1 Myung-Ju Ahn, MD, PhD A1 Wu-Chou Su, MD A1 Noboru Yamamoto, MD, PhD A1 Dong-Wan Kim, MD, PhD A1 Jolanda Paolini, MSc A1 Tiziana Usari, BSc A1 Laura Iadeluca, PhD A1 Keith D. Wilner, PhD A1 Koichi Goto, MD, PhD PB Elsevier YR 2022 K1 Asia K1 Crizotinib K1 NSCLC K1 Phase 2 K1 ROS1 K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://www.sciencedirect.com/science/article/pii/S2666364322001308 LK http://dx.doi.org/https://doi.org/10.1016/j.jtocrr.2022.100406 DO https://doi.org/10.1016/j.jtocrr.2022.100406 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)